Nasoclear (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasoclear, is an alpha‑adrenergic agonist (imidazoline decongestant) presented as a nasal spray for topical nasal use. It provides temporary relief of nasal congestion caused by the common cold, sinusitis, or allergic rhinitis in adults and children when appropriate.

GNH USA supplies Nasoclear as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts on nasal mucosal vessels to relieve congestion in several common upper‑respiratory conditions.

- Common cold nasal congestion: reduces swelling of nasal passages for temporary breathing ease. - Sinusitis‑related congestion: alleviates blockage associated with sinus inflammation. - Allergic rhinitis: diminishes nasal obstruction caused by allergic reactions.

Xylometazoline Hydrochloride may cause local or systemic reactions, though most are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation. - Mild nasal dryness. - Sneezing shortly after application. - Headache. - Transient taste disturbance.

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe hypertension. - Cardiac arrhythmias. - Allergic reactions such as rash, itching, or swelling. - Nasal septum perforation with prolonged misuse.

Before using Nasoclear, consider the following safety measures.

- Age restriction: avoid use in children under the age specified by local regulations. - Duration limit: do not exceed recommended treatment period (typically no more than 3‑5 days) to prevent rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: consult a healthcare professional, as safety data are limited. - Drug interactions: review concomitant medications for potential adrenergic effects. - Store at room temperature: keep in the original container, protect from moisture and heat.

Xylometazoline Hydrochloride can interact with other agents that affect vascular tone or adrenergic activity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive response. - Systemic decongestants (e.g., pseudoephedrine): risk of excessive vasoconstriction.

Moderate Interactions (Monitor Closely):\n- Antihypertensive drugs: possible attenuation of blood‑pressure‑lowering effect. - Tricyclic antidepressants: may increase sympathetic activity. - Beta‑blockers: monitor for additive cardiovascular effects.